Data showing high implant survival rate for Episealer® accepted for publication
Episurf Medical (Nasdaq: EPIS B) today announces that post-market surveillance survival data for the Episealer® Knee implant has been compiled and accepted for scientific publication in the peer-reviewed journal Surgical Technology International. The data shows a cumulative survival rate of >96% over 7 years. The publication, Patient-specific implants for focal cartilage lesions in the knee: implant survivorship analysis up to seven years post-implantation, by L. Ryd, K. Flodström and M. T. Manley focuses on survival data for 682 Episealer® knee implants implanted between 2012 and 2020. "